Received May 11, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | UNK | — |
Second shingles shot was 8 moths after the first one; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Previously administered products included Shingles vaccine (received the first dose of Shingrix). On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced drug dose administration interval too long (Verbatim: Second shingles shot was 8 moths after the first one). The outcome of the drug dose administration interval too long was not applicable. Additional Information: GSK Receipt date: 04-MAY-2026 This case was reported by a patient via interactive digital media. The patient asks will it stills protect me from getting Shingles. The batch number was not provided, and we are unable to contact the reporter.